ACTIVE

Cellistic

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-13,5 M €
+0.6% YoY
Revenue
8,6 M €
+115.1% YoY
Equity
-44,3 M €
-21.4% YoY
Workforce
61,2 ETP
-8.2% YoY

What does Cellistic do?

Cellistic is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mont-Saint-Guibert. It employs on average 61,2 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0740.785.238
Incorporation
06/01/2020
Legal form
Public limited company
Registered office
Rue Edouard Belin 2
1435 Mont-Saint-Guibert · WallonieSee on map
Contributed capital
6 331 124,91 €
Latest accounts
31/12/2025
Average workforce
61,2 ETP
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology21100Manufacture of basic pharmaceutical products21100Manufacture of basic pharmaceutical products
Joint committees (1)
  • 20700
Signals
Healthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 6 financial years

202520242023202220212020
Income statement
Revenue8,6 M €4 M €––––
EBITDA-4,2 M €-6 M €-7,1 M €-4,2 M €-998,4 k €-3,2 M €
Operating result-11,3 M €-10,7 M €-10,2 M €-6,6 M €-1,7 M €-3,4 M €
Net result-13,5 M €-13,6 M €-11,6 M €-6,6 M €-1,8 M €-3,5 M €
Balance sheet
Equity-44,3 M €-36,5 M €-17,2 M €-11,3 M €-4,7 M €-2,9 M €
Total assets41,6 M €39,3 M €27,8 M €9 M €1,8 M €1,5 M €
Cash831,7 k €334,1 k €878,7 k €158,9 k €108,7 k €6,9 k €
Debts85 M €75,6 M €45 M €20,4 M €6,4 M €4,3 M €
Other
Workforce61,2 ETP66,7 ETP61,4 ETP24,2 ETP12,1 ETP35,2 ETP
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Jason Conner

Director · since 05 mars 2026

Active

Ended mandates

Gustavo Mahler

Director · since 07 juin 2024

Ended
Stefan Braam

Director · since 30 décembre 2019 · until 07 juin 2024

Ended
Stefan Braam

Director · since 30 décembre 2019

Ended
At this address

Other companies at this address

CompanyCBE no.
CELYNTRA THERAPEUTICS● Active
0737.829.015
Ncardia Holding● Active
0565.979.162
Annual accounts

Full financial information

202520242023202220212020
Type of accountFull modelFull modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/07/2019
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months18 months
Filing date16/06/202622/10/202510/06/202630/06/202323/09/202230/09/2021
General meeting05/06/202630/09/202507/06/202420/06/202309/09/202223/09/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

7 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202505/06/202616/06/2026FrenchPDF
Full model31/12/202430/09/202522/10/2025FrenchPDF
Abridged modelCorrection31/12/202307/06/202410/06/2026FrenchPDF
Abridged model31/12/202307/06/202424/07/2024FrenchPDF
Abridged model31/12/202220/06/202330/06/2023FrenchPDF
Abridged model31/12/202109/09/202223/09/2022FrenchPDF
Abridged model31/12/202023/09/202130/09/2021FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Jason Conner

Director · since 05 mars 2026

Active

Ended mandates

Gustavo Mahler

Director · since 07 juin 2024

Ended
Stefan Braam

Director · since 30 décembre 2019 · until 07 juin 2024

Ended
Stefan Braam

Director · since 30 décembre 2019

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates12/06/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates07/05/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates26/08/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates21/06/2024
    DENOMINATION
    PDF
  • Registered office06/03/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DIVERS - SIEGE SOCIAL - CAPITAL, ACTIONS
    PDF
  • Mandates05/10/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates21/06/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Other08/01/2020
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-13,5 M €↑
  2. 2024
    Annual accounts 2024-13,6 M €↓
  3. 2023
    Annual accounts 2023-11,6 M €↓
  4. 2023
    Name changeCellistic
  5. 2022
    Annual accounts 2022-6,6 M €↓
  6. 2021
    Annual accounts 2021-1,8 M €↑
  7. 2021
    Name changeNcardia Belgium
  8. 2020
    Annual accounts 2020-3,5 M €
  9. 06/01/2020
    IncorporationPublic limited company